SCHEMBL17289013

SCHEMBL17289013

C=C(c1ccc(Cl)cc1)P(=O)(O)OCC

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.43
HTT P42858 1/20 0.39
POLB P06746 2/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GAA P10253 1/20 0.37
CTDSP1 Q9GZU7 1/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
NR1I2 O75469 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
MAOB P27338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17289237 0.85 ALDH1A1 (0.46) SMN1; SMN2NPC1ALDH1A1KDM4EMAPT
SCHEMBL9301199 0.83 KMT2A (0.41) HTTPOLBNPC1ALDH1A1MAPT
SCHEMBL9714149 0.83 POLB (0.45) SMN1; SMN2POLBALDH1A1MAPTLMNA
SCHEMBL11041660 0.78 SMN1; SMN2 (0.41) SMN1; SMN2HTTPOLBNPC1ALDH1A1
SCHEMBL16868449 0.74 NPSR1 (0.51) SMN1; SMN2POLBNPC1MAPTLMNA
SCHEMBL28422094 0.74 CES2 (0.46) ALDH1A1KDM4EMAPTLMNAL3MBTL1
SCHEMBL11515099 0.72 SMN1; SMN2 (0.49) SMN1; SMN2HTTPOLBALDH1A1KDM4E
SCHEMBL914714 0.72 NPC1 (0.48) SMN1; SMN2POLBNPC1ALDH1A1MAPT
SCHEMBL11044692 0.71 NR1I2 (0.46) POLBNPC1ALDH1A1KDM4EMAPT
SCHEMBL914602 0.70 PPARD (0.42) SMN1; SMN2HTTPOLBNPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9493494-B2 Phosphinine oxide derivative and preparation method thereof KNU-INDUSTRY COOPERATION FOUNDATION (KR) 2016-11-15 US disclosed
US-20150344506-A1 NOVEL PHOSPHININE OXIDE DERIVATIVE AND PREPARATION METHOD THEREOF KNU-INDUSTRY COOPERATION FOUNDATION (KR) 2015-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344506-A1 NOVEL PHOSPHININE OXIDE DERIVATIVE AND PREPARATION METHOD THEREOF PHOSPHO1, PPIP5K2, ITPA SMN1; SMN2 4065/4885HTT 4448/4885POLB 2599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.